Characterization of Dynamic Stability in Normal Pressure Hydrocephalus and Parkinson's Disease
NCT ID: NCT05998473
Last Updated: 2023-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2023-06-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pedunculopontine Nucleus Stimulation for Gait Disorders in Parkinson's Disease
NCT02055261
DBS of the MLR for Gait and Balance Disorders in PD Patients
NCT02931097
Gait Analysis in Neurological Disease
NCT02994719
Crossover Versus Stabilometric Platform in Parkinson's Disease
NCT02098577
Parkinson's Disease, Diagnostic Observations (PADDO)
NCT01249768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal pressure hydrocephalus
Patients with a diagnosis of normal pressure hydrocephalus and who performed a gait analysis in laboratories
Dynamic stability measurement
The subject is asked to walk 8 meters 3 times: at free speed, at fast speed, and with large steps.
Parkinson's disease
Patients with a diagnosis of Parkinson's disease and who performed a gait analysis in laboratories
Dynamic stability measurement
The subject is asked to walk 8 meters 3 times: at free speed, at fast speed, and with large steps.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dynamic stability measurement
The subject is asked to walk 8 meters 3 times: at free speed, at fast speed, and with large steps.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient who performed a walking test in the Laboratory Analysis and Restoration of Movement
* Diagnosis of normal pressure hydrocephalus or Parkinson's disease
Exclusion Criteria
* Presence of an other neurologic disease or of any disease associated with motor disorders in lower limb.
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Henri Mondor University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emilie Hutin
Co-director of laboratory
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emilie Hutin
Role: PRINCIPAL_INVESTIGATOR
Henri Mondor University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laboratoire Analyse et Restauration du Mouvement
Créteil, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A01762-43
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.